6.4.2017

Study: Diagnosis of respiratory tract infections caused by human bocavirus 1

Human bocavirus 1 (HBoV1) causes respiratory tract infections in infants and children. Diagnosis of acute HBoV1 infections is challenging as viral DNA is frequently detected in asymptomatic controls and as co-finding with other viruses. Recently developed novel HBoV1 mRNA and antigen tests may improve the diagnosis of acute HBoV1 infections.

Read the entire article here.

Press release: ArcDia launches a quick and automated COVID-19 antigen test with superior performance

Press release: Bruker to distribute ArcDia’s mariPOC® products for automated antigen POCT of COVID-19 and other infectious diseases in Central Europe

Press release: ArcDia Ltd’s automated coronavirus point-of-care test CE marked and available

Press Release: ArcDia Ltd reports a breakthrough in the development of an automated coronavirus point-of-care test

Press Release: ArcDia’s products would allow testing of all respiratory tract and COVID-19 patients in Finland

Press Release: ArcDia International Ltd develops a COVID-19 test for primary care

Pathogen Detection in Perianal Streptococcal Dermatitis

Mr. Vesa Kemppainen appointed as the new CEO

New mariPOC® publication: Evaluation of a Gastrointestinal Pathogen Panel Immunoassay in Stool Testing of Patients with Suspected Clostridioides (Clostridium) difficile Infection.

New mariPOC® publication: Comparison of phenotypic and genotypic diagnosis of acute human bocavirus 1 infection in children.

ArcDia has entered into an exclusive license agreement with Xinhua Healthcare for the commercialisation of ArcDia’s mariPOC® technology in China

mariPOC® ensures lower probability for C. difficile misdiagnosis with precision

New research data shows that influenza antigen testing correlates best with the infectivity period

Press release: New test for detection of C. difficile infection

New QuickStrepA

Study: Diagnosis of respiratory tract infections caused by human bocavirus 1

New mariPOC influenza A virus test with significantly improved sensitivity

New test for Flu A

World’s fastest antibiotic resistance testing

New mariPOC® Gastro test available

Detection and monitoring of human bocavirus 1 infection by a new rapid antigen test

ArcDia contributes solving the global problem of antimicrobial resistance

Press release: Spanish clinical study demonstrates mariPOC’s excellent performance

ArcDia is developing pandemics preparedness

The diagnostics of group A streptococcus from pharyngeal swab samples by bacterial culture is challenged by a novel mariPOC point of care test.

The Flu Season Has Begun – mariPOC® Helps

Nobel Prize awarded to mariPOC® sister technology

The Evolution of Rapid POC Tests for Infectious Disease Diagnostics: An Exclusive SelectScience Interview

ArcDia Receives Frost & Sullivan Award for Point-of-Care Product Leadership!

ArcDia launches world’s first antigen test for human bocavirus – Press Release

New press release

Study: Diagnosis of respiratory tract infections caused by human bocavirus 1

ArcDia International Oy Ltd.

Links

Follow us

Do you want to receive mariPOC® newsletter?